Baker Bros. Advisors LP: holdings and changes
Number 71 of the top 100 funds by copy return. Baker Bros. Advisors LP reported 79 US stocks worth $21.0B for the quarter ending 2026-09-30 and changed 5 new, 6 added, 11 trimmed and 9 sold since 2026-06-30.
Copy return, 4 quarters+40.3%
US 500, same time+14.5%
Size$21.0B
Stocks79
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| INCY Incyte Corporation | 17.79% | $3.7B | 30,762,652 | |
| BEIGENE LTD Beigene LTD | 15.40% | $3.2B | 8,832,335 | |
| RVMD Revolution Medicines INC | TRIM -7% | 10.40% | $2.2B | 10,637,318 |
| KOD Kodiak Sciences INC | ADD +10% | 9.87% | $2.1B | 21,860,941 |
| MDGL Madrigal Pharmaceuticals INC | 5.15% | $1.1B | 2,143,131 | |
| INSM Insmed INC. | 4.78% | $1.0B | 8,796,111 | |
| KYMR Kymera Therapeutics INC | 4.61% | $968M | 8,657,242 | |
| ACADIA PHARMAC Acadia Pharmacutical INC | 4.12% | $865M | 42,912,904 | |
| GRAL Grail INC | 2.69% | $564M | 4,028,614 | |
| SMMT Summit Therapeutics | 2.64% | $554M | 32,786,348 | |
| RYTM Rhythm Pharmaceuticals INC | 2.54% | $534M | 5,604,483 | |
| PRAX Praxis Precision Medicines I | 2.43% | $511M | 1,753,198 | |
| ABCL Abcellera Biologics INC | 2.29% | $482M | 33,012,139 | |
| ALKS Alkermes PLC | 1.93% | $406M | 10,012,267 | |
| CELC Celcuity INC | TRIM -39% | 1.82% | $383M | 4,815,792 |
| KNSA Kiniksa Pharmaceuticals Intl | 1.01% | $212M | 2,834,643 | |
| IDYA Ideaya Biosciences INC | 0.92% | $192M | 5,010,030 | |
| EWTX Edgewise Therapeutics INC | 0.72% | $150M | 3,701,719 | |
| REPL Replimune Group INC | 0.70% | $146M | 11,045,336 | |
| ROIV Roivant Sciences LTD | TRIM -22% | 0.64% | $134M | 3,660,352 |
| ARWR Arrowhead Pharmaceuticals, INC. | TRIM -14% | 0.53% | $112M | 1,709,053 |
| NRIX Nurix Therapeutics INC | 0.53% | $110M | 4,658,556 | |
| IMVT Immunovant INC | TRIM -49% | 0.45% | $94M | 2,770,377 |
| CLDX Celldex Therapeutics INC | ADD +117% | 0.40% | $83M | 2,564,984 |
| DNLI Denali Therapeutics INC | 0.37% | $77M | 3,734,336 | |
| DNTH Dianthus Therapeutics INC | 0.36% | $75M | 852,164 | |
| RAPP Rapport Therapeutics INC | 0.25% | $52M | 1,547,090 | |
| GLUE Monte Rosa Therapeutics INC | 0.25% | $52M | 4,345,736 | |
| RLAY Relay Therapeutics INC | 0.24% | $51M | 2,826,783 | |
| IONS Ionis Pharmaceuticals INC | TRIM -50% | 0.22% | $46M | 1,023,864 |
| GPCR Structure Therapeutics INC | 0.21% | $45M | 1,432,529 | |
| ELVN Enliven Therapeutics INC | 0.20% | $42M | 905,191 | |
| BCYC Bicycle Therapeutics PLC | 0.19% | $40M | 10,885,357 | |
| PRLD Prelude Therapeutics INC | 0.19% | $40M | 10,123,824 | |
| MIRM Mirum Pharmaceuticals, INC. | 0.18% | $38M | 445,975 | |
| DSGN Design Therapeutics INC | ADD +12% | 0.18% | $38M | 2,988,144 |
| IMTX Immatics N.V | TRIM -55% | 0.18% | $37M | 4,256,682 |
| STOK Stoke Therapeutics INC | TRIM -61% | 0.16% | $34M | 1,313,999 |
| TRDA Entrada Therapeutics, INC. | 0.15% | $32M | 5,072,730 | |
| NGNE Neurogene INC Com | 0.13% | $28M | 991,691 | |
| XNCR Xencor INC | 0.13% | $28M | 1,102,106 | |
| SENSEI BIOTHER Sensei Biotherapeutics INC | TRIM -38% | 0.11% | $24M | 803,425 |
| ABSI Absci Corporation | 0.11% | $23M | 2,134,803 | |
| IRON Disc Medicine INC | 0.11% | $23M | 349,657 | |
| RCUS Arcus Biosciences INC | 0.10% | $22M | 844,816 | |
| GENB Generate Biomedicines INC | 0.10% | $21M | 1,423,602 | |
| TSHA Taysha Gene Therapies INC Com Shs | 0.09% | $20M | 4,004,756 | |
| AKTS Aktis Oncology INC | 0.09% | $19M | 996,351 | |
| JBIO Jade Biosciences INC | 0.08% | $17M | 1,230,426 | |
| DBVT Dbv Technologies S A | 0.08% | $17M | 1,461,425 | |
| TRAX First Tracks Biotherapeutics | BUY | 0.08% | $17M | 472,932 |
| PBLS Parabilis Medicines, INC. | 0.08% | $16M | 500,000 | |
| TECX Tectonic Therapeutic INC | 0.07% | $14M | 607,788 | |
| CYTK Cytokinetics INC. | 0.07% | $14M | 211,267 | |
| XENE Xenon Pharmaceuticals INC | 0.07% | $14M | 370,208 | |
| CTMX Cytomx Therapeutics INC | 0.06% | $14M | 4,975,826 | |
| DYN Dyne Therapeutics INC | 0.06% | $13M | 813,449 | |
| SCTX Scribe Therapeutics INC | BUY | 0.06% | $13M | 688,691 |
| FRNM Freenome INC | BUY | 0.06% | $12M | 794,908 |
| MPLT Maplight Therapeutics INC | ADD +220% | 0.06% | $12M | 1,166,763 |
| BNTX Biontech Se | 0.06% | $12M | 119,743 | |
| SERA Sera Prognostics INC | 0.05% | $12M | 5,498,170 | |
| EVMN Evommune INC | ADD +46% | 0.05% | $10M | 1,234,794 |
| NTLA Intellia Therapeutics INC | TRIM -11% | 0.05% | $10M | 829,053 |
| AVLN Avalyn Pharma INC | 0.05% | $10M | 350,000 | |
| AVTX Avalo Therapeutics INC | 0.04% | $8M | 550,000 | |
| TNGX Tango Therapeutics INC | 0.04% | $8M | 333,333 | |
| LBRX Lb Pharmaceuticals INC | 0.04% | $8M | 200,000 | |
| ARTARA THERAPE Artara Therapeutics INC | ADD +90% | 0.03% | $6M | 1,843,795 |
| CERS Cerus Corp | TRIM -64% | 0.03% | $6M | 2,333,155 |
| VTVT Vtv Therapeutics INC Cl A New | 0.02% | $5M | 148,314 | |
| QTTB Q32 Bio INC. | BUY | 0.02% | $4M | 547,945 |
| EIKN Eikon Therapeutics INC | 0.02% | $4M | 555,555 | |
| IMNM Immunome INC | 0.01% | $1M | 55,306 | |
| SANA Sana Biotechnology INC | 0.00% | $900k | 310,483 | |
| TCRX Tscan Therapeutics INC | 0.00% | $900k | 2,784,792 | |
| ALGS Aligos Therapeutics, INC. | 0.00% | $500k | 83,055 | |
| SKYE Skye Bioscience INC Com | BUY | 0.00% | $300k | 196,905 |
| TYRA Tyra Biosciences INC | 0.00% | $200k | 10,607 | |
| CRINETICS PHAR Crinetics Pharmaceuticals In | SELL | 0% | was $88M | 0 |
| ALMS Alumis INC | SELL | 0% | was $57M | 0 |
| VRDN Viridian Therapeutics INC | SELL | 0% | was $44M | 0 |
| SION Sionna Therapeutics INC | SELL | 0% | was $18M | 0 |
| VSTM Verastem INC | SELL | 0% | was $10M | 0 |
| SGMT Sagimet Biosciences INC. | SELL | 0% | was $7M | 0 |
| WVE Wave Life Sciences LTD | SELL | 0% | was $5M | 0 |
| SKYE Skye Bioscience INC | SELL | 0% | was $1M | 0 |
| SRZN Surrozen INC | SELL | 0% | was $0k | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2023-06-30 → 2023-09-30 | +1.4% | -3.6% |
| 2023-09-30 → 2023-12-31 | +8.5% | +11.2% |
| 2024-03-31 → 2024-06-30 | -5.2% | +4.0% |
| 2024-06-30 → 2024-09-30 | +19.4% | +5.4% |
| 2024-09-30 → 2024-12-31 | -0.0% | +2.1% |
| 2024-12-31 → 2025-03-31 | +2.5% | -4.6% |
| 2025-03-31 → 2025-06-30 | +8.0% | +10.5% |
| 2025-06-30 → 2025-09-30 | +31.0% | +7.8% |
| 2025-09-30 → 2025-12-31 | +15.6% | +2.4% |
| 2025-12-31 → 2026-03-31 | -1.4% | -4.6% |
| 2026-03-31 → 2026-06-30 | +13.0% | +14.8% |
| 2026-06-30 → 2026-09-30 | +8.9% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP